Opioid Effectiveness for Acute Pain Reassessed in Largest Study to Date

A comprehensive review published in the journal Drugs has found that opioid medications provide limited, short-term relief for most acute pain conditions, with some cases showing no meaningful benefit, according to researchers from the University of Sydney. The analysis, which evaluated 59 systematic reviews covering over 50 acute pain conditions, challenges the widespread use of opioids for short-term pain management.

Key Findings of the Study

The study, led by Associate Professor Christina Abdel Shaheed, found that opioids offered only modest pain relief for conditions such as dental surgery, childbirth, and traumatic limb injuries. However, for many common acute pain scenarios—including kidney stone pain, post-tonsillectomy pain, and neonatal respiratory support—opioids performed no better than a placebo.

“Opioids are among the most commonly prescribed treatments for acute pain, however, our review found that they did not provide large or lasting pain relief compared with placebo for the vast majority of acute pain conditions,” Abdel Shaheed said. The research also highlighted that pain relief from opioids typically lasted only a few hours, with benefits diminishing over time.

Side Effects and Safety Concerns

Opioids were associated with increased risks of side effects, including nausea and vomiting, when used for acute musculoskeletal pain, post-surgical pain, and traumatic limb injuries. The study emphasized that while short-term use might reduce pain for specific conditions, prolonged use carries significant risks, including tolerance, dependence, and overdose.

“Persistent use of opioid medicines can develop quickly following first-time use, sometimes within days,” said co-first author Dr. Stephanie Mathieson. The researchers also noted that many clinical trials failed to adequately report side effects, suggesting the true risks of opioid use may be underreported.

Recommendations for Patients and Healthcare Providers

The study urges healthcare providers to prescribe opioids cautiously, recommending the lowest effective dose for the shortest duration possible. Patients should be informed of potential harms, including the risk of dependence, when these medications are prescribed for acute pain.

“These findings are important for patients across all age groups who experience acute pain, doctors treating these conditions, and policy makers who regulate the safe use of these medicines in the community,” said co-first author Associate Professor Joshua Zadro.

Why This Matters

This study adds to growing concerns about the overprescription of opioids, which have contributed to the global opioid crisis. The Centers for Disease Control and Prevention (CDC) previously recommended non-opioid alternatives for chronic pain, but this research extends those concerns to acute pain management. The findings could influence future guidelines for pain treatment and public health policies.

What’s Next?

Researchers call for further studies to improve the quality of safety data and explore alternative pain management strategies. The study’s authors also emphasized the need for patient education to reduce reliance on opioids for short-term pain, particularly as the medical community seeks safer, long-term solutions.